TP53 and neoplasm: In addition, the additional mutation of an acetylation site at Lys98 in mouse p53 (Lys101 in human p53) completely abolishes the ability to repress the expression of SLC7A11, resulting in impaired ferroptosis and tumor suppression in mouse xenograft models [338].